Francis Chou
Chou Associates Management
Chou Associates Management Portfolio 13F
Francis Chou Holdings Activity
- Portfolio value:
- $237.22M≈ (+$3M≈)
- Previous value:
- $233.80M≈
- # of changes:
- 2
- New positions:
- 0
- Reported for:
- 31 Mar 2018 (Q1)
- Latest filing date:
- 11 May 2018
Chou Associates Management has disclosed a total of 2 changes to the portfolio in the (2018 Q1) SEC report(s): increased the number of shares of 2 position(s).
What did Francis Chou invest in during 2018 Q1?
In the 2018 Q1 report(s) the following change has been made to the top investments: (VRX) Valeant Pharmaceuticals International Inc (added shares +1,006.77%).
2 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Valeant Pharmaceuticals International Inc
|
+1,006.77%
|
$15.92
|
|
11.07%
|
2016 Q1
|
≈ 2.25 years
|
||||
|
|
ENDO HEALTH SOLUTIONS INC COM
|
+1,000.00%
|
$5.94
|
|
2.20%
|
2017 Q1
|
≈ 1.25 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.